HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
2,5-Furandione, 3,3,4,4-tetrafluorodihydro- → trans-4-[(7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepin-1-yl)amino]-2,2,3,3-tetrafluoro-4-oxobutanoic acid
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | 2,5-Furandione, 3,3,4,4-tetrafluorodihydro- | HCID 69686 | — |
| Edukt | trans-7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepine-1-amine | HCID 70883458 | — |
| Lösungsmittel | 1,4-Dioxane | HCID 31275 | — |
| Produkt | trans-4-[(7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepin-1-yl)amino]-2,2,3,3-tetrafluoro-4-oxobutanoic acid | HCID 86599862 | 74,7% |
Reaktionsschritte
Tetrafluorosuccinic anhydride (5.35 μL, 0.05 mmol) was added to trans-7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepine-1-amine (10 mg, 0.03 mmol) in 1 mL of dioxane. The resulting mixture was stirred at room temperature for 30 minutes. Dioxane was removed by evaporation under reduced pressure and ethyl acetate and 2% citric acid were added. The organic layer was washed with brine, dried (Na2SO4) and evaporated to give trans-4-[(7-chloro-2,3,4,14b-tetrahydro-1H-dibenzo[b,f]pyrido[1,2-d][1,4]oxazepin-1-yl)amino]-2,2,3,3-tetrafluoro-4-oxobutanoic acid (10.6 mg, 51%). Data: (m/z)=472 (M+H)+.
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US07737136B2 |
| Quelldatensatz | uspto-grants-2010_06 |
| ORD ID | ord-90f526e606364684b29c4973829d1a40 |
| Quellennotiz | uspto-grants-2010_06 |